Dr. White On RTOG 1119 Trial for Breast Cancer

Video

In Partnership With:

Julia White, MD, professor of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, discusses RTOG-1119 trial for patients with breast cancer.

Julia White, MD, professor of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, discusses RTOG-1119 trial for patients with breast cancer.

RTOG-1119, is an ongoing randomized phase II trial focusing on adding lapatinib (Tykerb) to whole-brain radiation therapy to improve cancer control of patients with HER2-positive breast cancer who have brain metastases. In HER2-positive metastatic breast cancer, there is an increasing number of agents that extend progression-free survival and overall survival, but there is still a high rate of failure in the brain for this subtype of cancer, White explains.

The standard of care for brain metastases is radiotherapy initiated to the whole brain. However, stereotactic surgery targets the cancer with conformal radiation. What this study wants to discover is whether the addition of lapatinib to radiation therapy can extend cancer control in the brain, says White.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD